DrugPatentWatch Database Preview

Details for Patent: 8,486,973

« Back to Dashboard

Which drugs does patent 8,486,973 protect, and when does it expire?

Patent 8,486,973 protects SUBSYS and is included in one NDA.

This patent has nine patent family members in nine countries.

Summary for Patent: 8,486,973

Title:	Sublingual fentanyl spray
Abstract:	The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
Inventor(s):	Kottayil; S. George (Phoenix, AZ), Goskonda; Venkat R. (Gurnee, IL), Zhu; Zhongyuan (Vernon Hills, IL), Kattookaran; Linet (Des Plaines, IL), Parikh; Neha (Chicago, IL)
Assignee:	Insys Therapeutics, Inc. (Phoenix, AZ)
Application Number:	12/221,333
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,486,973
Patent Claim Types: see list of patent claims	Use; Formulation; Composition; Delivery; Device;

Drugs Protected by US Patent 8,486,973

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-001	Jan 4, 2012		RX	Yes	No						TREATMENT OF PAIN
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-002	Jan 4, 2012		RX	Yes	No						TREATMENT OF PAIN
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-003	Jan 4, 2012		RX	Yes	Yes						TREATMENT OF PAIN
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-004	Jan 4, 2012		RX	Yes	No						TREATMENT OF PAIN
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-005	Jan 4, 2012		RX	Yes	No						TREATMENT OF PAIN

International Family Members for US Patent 8,486,973

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008282743
Canada	2698749
Denmark	2180844
European Patent Office	2180844
Spain	2668366